Literature DB >> 17044102

A genome-wide scan for schizophrenia and psychosis susceptibility loci in families of Mexican and Central American ancestry.

M A Escamilla1, A Ontiveros, H Nicolini, H Raventos, R Mendoza, R Medina, R Munoz, D Levinson, J M Peralta, A Dassori, L Almasy.   

Abstract

Schizophrenia is a complex psychiatric disorder, likely to be caused in part by multiple genes. In this study, linkage analyses were performed to identify chromosomal regions most likely to be associated with schizophrenia and psychosis in multiplex families of Mexican and Central American origin. Four hundred and fifty-nine individuals from 99 families, containing at least two siblings with hospital diagnoses of schizophrenia or schizoaffective disorder, were genotyped. Four hundred and four microsatellite markers were genotyped for all individuals and multipoint non-parametric linkage analyses were performed using broad (any psychosis) and narrow (schizophrenia and schizoaffective disorder) models. Under the broad model, three chromosomal regions (1pter-p36, 5q35, and 18p11) exhibited evidence of linkage with non-parametric lod (NPL) scores greater than 2.7 (equivalent to empirical P values of less than 0.001) with the peak multipoint NPL = 3.42 (empirical P value = 0.00003), meeting genomewide evidence for significant linkage in the 1pter-p36 region. Under the narrow model, the same three loci showed (non-significant) evidence of linkage. These linkage findings (1pter-p36, 18p11, and 5q35) highlight where genes for psychosis and schizophrenia are most likely to be found in persons of Mexican and Central American ancestry, and correspond to recent linkages of schizophrenia or psychosis in other populations which were formed in part from emigrants from the Spanish empire of the 15th and 16th centuries. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17044102     DOI: 10.1002/ajmg.b.30411

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  14 in total

1.  Associations between DRDs and schizophrenia in a Korean population: multi-stage association analyses.

Authors:  Kyu Young Lee; Eun-Jeong Joo; Yong Ick Ji; Duk-Hwan Kim; Joo Bae Park; In-Won Chung; Sang Ick Lee; Yeon Ho Joo; Yong Min Ahn; Joo Yun Song; Yong Sik Kim
Journal:  Exp Mol Med       Date:  2011-01-31       Impact factor: 8.718

2.  Revisiting schizophrenia linkage data in the NIMH Repository: reanalysis of regularized data across multiple studies.

Authors:  Veronica J Vieland; Kimberly A Walters; Thomas Lehner; Marco Azaro; Kathleen Tobin; Yungui Huang; Linda M Brzustowicz
Journal:  Am J Psychiatry       Date:  2014-03       Impact factor: 18.112

Review 3.  Substance use disorder and schizophrenia: prevalence and sociodemographic characteristics in the Latin American population.

Authors:  Lorena Jiménez-Castro; Henriette Raventós-Vorst; Michael Escamilla
Journal:  Actas Esp Psiquiatr       Date:  2011-03-01       Impact factor: 1.196

4.  Substance use disorder comorbidity with schizophrenia in families of Mexican and Central American ancestry.

Authors:  Lorena Jiménez-Castro; Elizabeth Hare; Rolando Medina; Henriette Raventos; Humberto Nicolini; Ricardo Mendoza; Alfonso Ontiveros; Alvaro Jerez; Rodrigo Muñoz; Albana Dassori; Michael Escamilla
Journal:  Schizophr Res       Date:  2010-03-19       Impact factor: 4.939

5.  Neuropsychiatric Genetics of Psychosis in the Mexican Population: A Genome-Wide Association Study Protocol for Schizophrenia, Schizoaffective, and Bipolar Disorder Patients and Controls.

Authors:  Beatriz Camarena; Elizabeth G Atkinson; Mark Baker; Claudia Becerra-Palars; Lori B Chibnik; Raúl Escamilla-Orozco; Joanna Jiménez-Pavón; Zan Koenig; Carla Márquez-Luna; Alicia R Martin; Ingrid Pamela Morales-Cedillo; Ana Maria Olivares; Hiram Ortega-Ortiz; Alejandra Monserrat Rodriguez-Ramírez; Ricardo Saracco-Alvarez; Rebecca E Basaldua; Brena F Sena; Karestan C Koenen
Journal:  Complex Psychiatry       Date:  2021-08-24

6.  The value of regenotyping older linkage data sets with denser marker panels.

Authors:  Veronica J Vieland; Kimberly A Walters; Marco Azaro; Linda M Brzustowicz; Thomas Lehner
Journal:  Hum Hered       Date:  2014-06-21       Impact factor: 0.444

7.  Methionine sulfoxide reductase: a novel schizophrenia candidate gene.

Authors:  Consuelo Walss-Bass; Maria Clara Soto-Bernardini; Teresa Johnson-Pais; Robin J Leach; Alfonso Ontiveros; Humberto Nicolini; Ricardo Mendoza; Alvaro Jerez; Albana Dassori; Ivan Chavarria-Siles; Michael A Escamilla; Henriette Raventos
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-03-05       Impact factor: 3.568

8.  The serotonin transporter 5-HTTPR polymorphism is associated with current and lifetime depression in persons with chronic psychotic disorders.

Authors:  J Contreras; L Hare; B Camarena; D Glahn; A Dassori; R Medina; S Contreras; M Ramirez; R Armas; R Munoz; R Mendoza; H Raventos; A Ontiveros; H Nicolini; R Palmer; M Escamilla
Journal:  Acta Psychiatr Scand       Date:  2008-11-11       Impact factor: 6.392

9.  A genome-wide quantitative trait locus (QTL) linkage scan of NEO personality factors in Latino families segregating bipolar disorder.

Authors:  Byung Dae Lee; Suzanne Gonzalez; Erika Villa; Cynthia Camarillo; Marco Rodriguez; Yin Yao; Wei Guo; Deborah Flores; Alvaro Jerez; Henriette Raventos; Alfonso Ontiveros; Humberto Nicolini; Michael Escamilla
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-05-29       Impact factor: 3.358

10.  Meta-analysis of 32 genome-wide linkage studies of schizophrenia.

Authors:  M Y M Ng; D F Levinson; S V Faraone; B K Suarez; L E DeLisi; T Arinami; B Riley; T Paunio; A E Pulver; P A Holmans; M Escamilla; D B Wildenauer; N M Williams; C Laurent; B J Mowry; L M Brzustowicz; M Maziade; P Sklar; D L Garver; G R Abecasis; B Lerer; M D Fallin; H M D Gurling; P V Gejman; E Lindholm; H W Moises; W Byerley; E M Wijsman; P Forabosco; M T Tsuang; H-G Hwu; Y Okazaki; K S Kendler; B Wormley; A Fanous; D Walsh; F A O'Neill; L Peltonen; G Nestadt; V K Lasseter; K Y Liang; G M Papadimitriou; D G Dikeos; S G Schwab; M J Owen; M C O'Donovan; N Norton; E Hare; H Raventos; H Nicolini; M Albus; W Maier; V L Nimgaonkar; L Terenius; J Mallet; M Jay; S Godard; D Nertney; M Alexander; R R Crowe; J M Silverman; A S Bassett; M-A Roy; C Mérette; C N Pato; M T Pato; J Louw Roos; Y Kohn; D Amann-Zalcenstein; G Kalsi; A McQuillin; D Curtis; J Brynjolfson; T Sigmundsson; H Petursson; A R Sanders; J Duan; E Jazin; M Myles-Worsley; M Karayiorgou; C M Lewis
Journal:  Mol Psychiatry       Date:  2008-12-30       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.